Liver health in patients with chronic kidney disease
Part of Digestive system clinical trials.
This trial looks at how common fatty liver disease is in people with chronic kidney disease (CKD). It may help doctors understand the link between kidney and liver health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have chronic kidney disease (CKD) caused by tubule-glomerular diseases.
- You have either type 1 or type 2 diabetes along with CKD.
- You do not have liver cirrhosis or a history of hepatitis B or C.
- You are not pregnant and are not taking any medications that can harm the liver.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at the link between kidney disease and heart disease. It aims to understand how heart problems affect people with chronic kidney disease. The trial does not test a new drug, but rather follows patients to learn more about their health.
This study looks at how common kidney problems are in people with chronic liver disease who are admitted to Sohag University Hospital. If you qualify, doctors will check your kidney function after stopping certain medicines for a few days.
This study is looking at the relationship between the fat around your kidneys and chronic kidney disease, especially if you also have a fatty liver. It may help doctors understand how these conditions are connected.
This study checks cholesterol and fat levels in the blood of people with chronic kidney disease, comparing those with and without diabetes. It aims to understand how kidney disease affects lipid profiles.
This study collects health information from people with chronic kidney disease (CKD) and also from some people without CKD but with kidney risk factors. It helps doctors understand how CKD develops and how it’s managed in everyday life, not to test a new drug.
This study looks at how well we can predict heart and kidney problems in people who have both coronary heart disease and chronic kidney disease. By analyzing certain markers, researchers hope to create a better risk assessment tool.
Hear when a new Fatty Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.